Skip to main content
Skip to footer
EQL Pharma Investor Relations
eqlpharma.com
Contact
Svenska
About Us
IR Contact
Vision
Mission
Business Concept
Business Model
Objectives
The Share
Shareholders
Analyst
Financial Calendar
List change 2024
Reports
Annual Reports
Interim Reports
Corporate Governance
Management
Board of Directors
Board Committees
Auditor
Nomination Committee
General Meetings
Internal Control and Risk Management
Incentive programs
Articles of Association
Media
Press Releases
Presentations
About Us
IR Contact
Vision
Mission
Business Concept
Business Model
Objectives
The Share
Shareholders
Analyst
Financial Calendar
List change 2024
Reports
Annual Reports
Interim Reports
Corporate Governance
Management
Board of Directors
Board Committees
Auditor
Nomination Committee
General Meetings
Internal Control and Risk Management
Incentive programs
Articles of Association
Media
Press Releases
Presentations
Home
/
The Share
/
Analyst
About Us
IR Contact
Vision
Mission
Business Concept
Business Model
Objectives
The Share
Shareholders
Analyst
Financial Calendar
List change 2024
Reports
Annual Reports
Interim Reports
Corporate Governance
Management
Board of Directors
Board Committees
Auditor
Nomination Committee
General Meetings
Internal Control and Risk Management
Incentive programs
Articles of Association
Media
Press Releases
Presentations
Analyst
EQL Pharma’s stock is followed by the following analysts:
Carnegie
Erik Penser Bank
Kalqyl
